Key result
Liver disease and hepatic fibrosis are linked to higher atrial fibrillation risk.
Why the study?
Liver disease has recently been identified as a risk factor for atrial fibrillation, but the relationship and clinical interventions remain to be summarized.
Answers are grounded in this paper and cite their sources.
May inform AF risk stratification in liver disease; leaves open whether antifibrotic therapies alter incidence.
Atrial fibrillation (AFib) is a common type of cardiac arrhythmia, characterized by disorganized atrial electrical activity with features of irregularly irregular heart rhythm and often with rapid ventricular response increasing the risk of stroke and heart failure due to tachyarrhythmia. The pathophysiology mechanism of AFib is either triggered by atrial distension, abnormality in conducting system, catecholamine excess, or increased atrial irritation or automaticity. Risk factors include uncontrolled diabetes, obesity, obstructive sleep apnea, hypothyroidism, and certain stimulants. Based on recent research, liver disease has recently been identified as a risk factor for AFib. Considering the progression of chronic liver disease, this literature review aims to investigate and summarize the relationship between liver disease and AFib and explore clinical interventions that can be utilized to prevent AFib aggravation.
No takes yet. Share an insight, caveat, or question.
Palmar et al. (2023) conducted a review in Atrial Fibrillation and Liver Disease. Liver disease and hepatic fibrosis vs. Absence of liver disease was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: